£114.99

Pharmaceutical Industry Developments: Specialty Drugs, Coupons, Reverse Payments & Product Hopping (Pharmacology - Research, Safety Testing and Regulation)

Law

Price data last checked 12 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£115 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 79 days · 79 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 79 days • 1 price levels

Days at Price

Price Analysis

Most common price: £115 (79 days, 100.0%)

Price range: £115 - £115

Price levels: 1 different prices over 79 days

Description

Specialty drugs are one of the fastest-growing areas of health care spending. There is no one set definition of specialty drugs, although insurers and other health care payers often characterize them as prescription products requiring extra handling or administration that are used to treat complex diseases including hepatitis C, multiple sclerosis, and cancer. High cost can trigger a specialty drug designation. Biologics, or drugs derived from living cells, are often but not always deemed to be specialty drugs. This book provides background on specialty drugs. To put specialty drug development, distribution, and spending in context, the book provides information about broader U.S. prescription drug pricing, insurance, and regulatory trends. Furthermore, this book explains the difference between coupons and other pharmaceutical assistance and incentive programs offered by manufacturers, pharmacies, states, and nonprofit organizations; outlines federal laws and regulations and private-sector policies relating to coupons and other financial incentives for consumers/patients to purchase prescription drugs; and introduces and analyzes innovation and competition policy issues associated with the pharmaceutical industry.

Product Specifications

Format: hardcover
ASIN: 1634846494
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 01 February 2016
Listed Since: 08 January 2016

Barcode

No barcode data available

Pharmaceutical Industry Developments: Specialty Drugs, Coupons, Reverse Payments & Product Hopping (Pharmacology - Research, Safety Testing and Regulation)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Stem Cell Drugs - A New Generation of Biopharmaceuticals (Stem Cells in Clinical Applications)

Pharmacology Researcher Biographical Sketches & Research Summaries (Pharmacology - Research, Safety Testing and Regulation)

Pharmabetriebslehre

Generic Drugs: The Pay-for-Delay Problem (Public Health in the 21st Century Series)

Ethics and the Pharmaceutical Industry

Nutraceuticals and Natural Product Pharmaceuticals

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

The Science and Business of Drug Discovery: Demystifying the Jargon

Dose Finding in Drug Development (Statistics for Biology and Health)

Medicare Part D & Prescription Drugs (Health Care Issues, Costs and Access)

Pharmaceutical Microscopy

Theory and Practice of Contemporary Pharmaceutics

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

Challenges in Protein Product Development: 38 (AAPS Advances in the Pharmaceutical Sciences Series, 38)

An Introduction to P-Glycoprotein (Pharmacology - Research, Safety Testing and Regulation)

Knowledge Accumulation and Industry Evolution: The Case of Pharma-Biotech

Biopharmaceutical Drug Design and Development

Changing Innovation in the Pharmaceutical Industry: Globalization and New Ways of Drug Development

Biochemistry, Cell and Molecular Biology for Pharmacists and Health Professionals: From Biomolecules to Drug Development

Knowledge Accumulation and Industry Evolution: The Case of Pharma-Biotech

Smolen Controlled ∗drug∗ Bioavailability – Bioavailability Control By Drug Deliver: v. 3

PROPOFOL PHARMACOKINETICS MEDICAL US: Pharmacokinetics, Medical Uses & Potential Health Effects (Pharmacology-research, Safety Testing and Regulation)

An Introduction to Drug Carriers (Biochemistry Research Trends)

Site–Specific Drug Delivery – Cell Biology Medical & Pharmaceutical Aspects